Macrophage inflammatory protein 3α is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors

被引:306
作者
Dieu-Nosjean, MC
Massacrier, C
Homey, B
Vanbervliet, B
Pin, JJ
Vicari, A
Lebecque, S
Dezutter-Dambuyant, C
Schmitt, D
Zlotnik, A
Caux, C
机构
[1] Schering Plough Corp, Lab Immunol Res, F-69571 Dardilly, France
[2] DNAX Res Inst Mol & Cellular Biol Inc, Palo Alto, CA 94304 USA
[3] Ctr Hosp Edouard Herriot, INSERM, U346, F-69437 Lyon, France
关键词
dendritic cell; chemokine; migration; regulation; in vivo expression;
D O I
10.1084/jem.192.5.705
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dendritic cells (DCs) form a network comprising different populations that initiate and differentially regulate immune responses. Langerhans cells (LCs) represent a unique population of DCs colonizing epithelium, and we present here observations suggesting that macrophage inflammatory protein (MIP)-3 alpha plays a central role in LC precursor recruitment into the epithelium during inflammation. (a) Among DC populations, MIP-3 alpha was the most potent chemokine inducing the selective migration of in vitro-generated CD34(+) hematopoietic progenitor cell-derived LC precursors and skin LCs in accordance with the restricted MIP-3 alpha receptor (CC chemokine receptor 6) expression to these cells. (b) MIP-3 alpha was mainly produced by epithelial cells, and the migration of LC precursors induced by the supernatant of activated skin keratinocytes was completely blocked with an antibody against MIP-3 alpha. (c) In vivo, MIP-3 alpha was selectively produced at sites of inflammation as illustrated in tonsils and lesional psoriatic skin where MIP-3 alpha upregulation appeared associated with an increase in LC turnover. (d) Finally, the secretion of MIP-3 alpha was strongly upregulated by cells of epithelial origin after inflammatory stimuli (interleukin 1 beta plus tumor necrosis factor or) or T cell signals. Results of this study suggest a major role of MIP-3 alpha in epithelial colonization by LCs under inflammatory conditions and immune disorders, and might open new ways to control epithelial immunity.
引用
收藏
页码:705 / 717
页数:13
相关论文
共 70 条
[2]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[3]   In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas [J].
Bell, D ;
Chomarat, P ;
Broyles, D ;
Netto, G ;
Harb, GM ;
Lebecque, S ;
Valladeau, J ;
Davoust, J ;
Palucka, KA ;
Banchereau, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (10) :1417-1425
[4]   A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: The skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells [J].
Borkowski, TA ;
Letterio, JJ ;
Farr, AG ;
Udey, MC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (06) :2417-2422
[5]   Chemokines and the arrest of lymphocytes rolling under flow conditions [J].
Campbell, JJ ;
Hedrick, J ;
Zlotnik, A ;
Siani, MA ;
Thompson, DA ;
Butcher, EC .
SCIENCE, 1998, 279 (5349) :381-384
[6]  
CAUX C, 1990, BLOOD, V75, P2292
[7]   Respective involvement of TGF-β and IL-4 in the development of Langerhans cells and non-Langerhans dendritic cells from CD34+ progenitors [J].
Caux, C ;
Massacrier, C ;
Dubois, B ;
Valladeau, J ;
Dezutter-Dambuyant, C ;
Durand, I ;
Schmitt, D ;
Saeland, S .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (05) :781-791
[8]   CD34(+) hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha .2. Functional analysis [J].
Caux, C ;
Massacrier, C ;
Vanbervliet, B ;
Dubois, B ;
Durand, I ;
Cella, M ;
Lanzavecchia, A ;
Banchereau, J .
BLOOD, 1997, 90 (04) :1458-1470
[9]   CD34(+) hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha [J].
Caux, C ;
Vanbervliet, B ;
Massacrier, C ;
DezutterDambuyant, C ;
deSaintVis, B ;
Jacquet, C ;
Yoneda, K ;
Imamura, S ;
Schmitt, D ;
Banchereau, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :695-706
[10]  
Caux C, 1998, METHOD MICROBIOL, V25, P505